# Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects

> **NCT03034408** · PHASE2 · COMPLETED · sponsor: **Prof. Daniele Zullino** · enrollment: 37 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Nalmefene
- **DRUG:** Baclofen
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT03034408
- **Lead sponsor:** Prof. Daniele Zullino
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2018-12-17
- **Final completion:** 2018-12-17
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03034408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03034408, "Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03034408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
